Home >> Tag Archives: InSource Diagnostics—

Tag Archives: InSource Diagnostics—

InSource starts trial on Rx metabolism biomarkers

Aug. 25, 2016—InSource Diagnostics is enlisting research sites to enroll patients in the SPHERE Registry for a clinical trial designed to validate biomarkers in urine that predict genetic mutations that affect a patient’s ability to properly metabolize medications. The drugs in this study are opioids, benzodiazepines, tryclyclic antidepressants, and muscle relaxants. These include the two most highly prescribed pain drugs, ...

Read More »